PL2203160T3 - Farmakologiczne leczenie wspomagające związane z chirurgią filtracyjną jaskry - Google Patents

Farmakologiczne leczenie wspomagające związane z chirurgią filtracyjną jaskry

Info

Publication number
PL2203160T3
PL2203160T3 PL08799307T PL08799307T PL2203160T3 PL 2203160 T3 PL2203160 T3 PL 2203160T3 PL 08799307 T PL08799307 T PL 08799307T PL 08799307 T PL08799307 T PL 08799307T PL 2203160 T3 PL2203160 T3 PL 2203160T3
Authority
PL
Poland
Prior art keywords
treatment associated
filtration surgery
glaucoma filtration
adjunctive treatment
pharmacological
Prior art date
Application number
PL08799307T
Other languages
English (en)
Inventor
Stephen P Bartels
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of PL2203160T3 publication Critical patent/PL2203160T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL08799307T 2007-09-27 2008-09-08 Farmakologiczne leczenie wspomagające związane z chirurgią filtracyjną jaskry PL2203160T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97562007P 2007-09-27 2007-09-27
EP08799307.7A EP2203160B1 (en) 2007-09-27 2008-09-08 Pharmacological adjunctive treatment associated with glaucoma filtration surgery
PCT/US2008/075579 WO2009042377A1 (en) 2007-09-27 2008-09-08 Pharmacological adjunctive treatment associated with glaucoma filtration surgery

Publications (1)

Publication Number Publication Date
PL2203160T3 true PL2203160T3 (pl) 2013-11-29

Family

ID=40043043

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08799307T PL2203160T3 (pl) 2007-09-27 2008-09-08 Farmakologiczne leczenie wspomagające związane z chirurgią filtracyjną jaskry

Country Status (18)

Country Link
US (1) US20090087443A1 (pl)
EP (1) EP2203160B1 (pl)
JP (1) JP5249336B2 (pl)
KR (1) KR20100065166A (pl)
CN (1) CN101878026B (pl)
AU (1) AU2008305407B2 (pl)
BR (1) BRPI0817472A2 (pl)
CA (1) CA2699599C (pl)
CY (1) CY1114479T1 (pl)
DK (1) DK2203160T3 (pl)
ES (1) ES2424008T3 (pl)
HR (1) HRP20130817T1 (pl)
MX (1) MX2010003198A (pl)
PL (1) PL2203160T3 (pl)
PT (1) PT2203160E (pl)
SI (1) SI2203160T1 (pl)
TW (1) TWI366462B (pl)
WO (1) WO2009042377A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110295782A1 (en) * 2008-10-15 2011-12-01 Alexander Stojadinovic Clinical Decision Model
US20110077270A1 (en) * 2009-04-21 2011-03-31 Pfeffer Bruce A Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
WO2011140519A2 (en) 2010-05-07 2011-11-10 Medicus Biosciences, Llc In vivo gelling pharmaceutical pre-formulation
US10111985B2 (en) * 2011-08-10 2018-10-30 Medicus Biosciences, Llc Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
US11083821B2 (en) 2011-08-10 2021-08-10 C.P. Medical Corporation Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
CN104428014B (zh) 2012-05-11 2016-11-09 梅迪卡斯生物科学有限责任公司 针对视网膜脱离的生物相容性水凝胶治疗
EA201891724A1 (ru) * 2016-02-17 2019-01-31 Новартис Аг Антитела к tgf-бета2
US12027276B1 (en) 2017-10-27 2024-07-02 DecisionQ Corporation Methods, systems and devices for assessing wound healing
CN113382730B (zh) 2019-01-22 2025-02-25 阿克里斯生物医药有限公司 用于治疗受损的皮肤伤口愈合的选择性糖皮质激素受体修饰剂

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
ATE531812T1 (de) * 1997-12-05 2011-11-15 Scripps Research Inst Humanisierung von nager-antikörpern
US6242196B1 (en) * 1997-12-11 2001-06-05 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
AU4713499A (en) * 1998-06-27 2000-01-17 Photogenesis, Inc. Ophthalmic uses of ppargamma agonists and ppargamma antagonists
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ES2276038T3 (es) * 2002-01-14 2007-06-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para su obtencion, formulaciones farmaceuticas que los contienen y usos de los mismos.
JP4324480B2 (ja) * 2002-03-26 2009-09-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
JP2005521717A (ja) * 2002-03-26 2005-07-21 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
US6897224B2 (en) * 2002-04-02 2005-05-24 Schering Ag Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US7074806B2 (en) * 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US20060020001A1 (en) * 2002-12-23 2006-01-26 Allan Shepard Use of cathepsin k inhibitors for the treatment of glaucoma
CA2512257A1 (en) * 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004097410A1 (en) * 2003-04-30 2004-11-11 Pfizer Products Inc. Screening methods for cataractogenic risk
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
WO2005095401A1 (en) * 2004-03-22 2005-10-13 Boehringer Ingelheim Pharmaceuticals, Inc. Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
US20050230128A1 (en) * 2004-04-06 2005-10-20 Smith Bret A Replaceable trench blade
DE102004055633A1 (de) * 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US7417056B2 (en) * 2004-11-12 2008-08-26 Schering Ag 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
KR20090050091A (ko) * 2006-08-31 2009-05-19 보오슈 앤드 롬 인코포레이팃드 녹내장 또는 그의 진행을 치료 또는 예방하기 위한 조성물 및 방법
PT2061444E (pt) * 2006-09-11 2011-07-08 Bausch & Lomb Composições e métodos de tratamento, controlo, redução, melhoramento ou prevenção de alergias

Also Published As

Publication number Publication date
CN101878026A (zh) 2010-11-03
EP2203160B1 (en) 2013-07-17
SI2203160T1 (sl) 2013-11-29
AU2008305407B2 (en) 2012-12-20
TW200914014A (en) 2009-04-01
MX2010003198A (es) 2010-04-01
KR20100065166A (ko) 2010-06-15
JP2010540538A (ja) 2010-12-24
ES2424008T3 (es) 2013-09-26
CA2699599A1 (en) 2009-04-02
HK1145014A1 (en) 2011-03-25
JP5249336B2 (ja) 2013-07-31
HRP20130817T1 (hr) 2013-09-30
CY1114479T1 (el) 2016-10-05
DK2203160T3 (da) 2013-09-02
BRPI0817472A2 (pt) 2015-03-24
PT2203160E (pt) 2013-10-22
TWI366462B (en) 2012-06-21
AU2008305407A1 (en) 2009-04-02
CN101878026B (zh) 2013-11-20
US20090087443A1 (en) 2009-04-02
EP2203160A1 (en) 2010-07-07
WO2009042377A1 (en) 2009-04-02
CA2699599C (en) 2012-10-23

Similar Documents

Publication Publication Date Title
TWI366462B (en) Pharmacological adjunctive treatment associated with glaucoma filtration surgery
PL2526910T3 (pl) Urządzenie do leczenia jaskry
IL198179A0 (en) Ocular radiosurgery
GB0722592D0 (en) Surgeons headgear
PT2136748T (pt) Transplante da córnea
GB0713880D0 (en) Conjugate purification
GB0716605D0 (en) Skin antiseptics
IL194473A0 (en) Ocular allergy treatments
GB0711342D0 (en) Well treatment
EP2148667A4 (en) USE OF CYCLOHEXANHEXOL DERIVATIVES IN THE TREATMENT OF EYE DISEASES
GB0707208D0 (en) Novel disease treatments
ZA201000919B (en) Antibacterial combination therapy
GB0822101D0 (en) Ophthalmic irrigator
GB0716784D0 (en) Well treatment
IL205542A0 (en) Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
GB2451821B (en) Eye bath
AU316472S (en) Cannula
IL205752A0 (en) Octahydroquinolizines for antidiabetic treatment
GB0805106D0 (en) Visor
GB0808690D0 (en) Therapeutic use
GB0714430D0 (en) Disposable Eye Bath
GB0713320D0 (en) Oval snooker
GB0601091D0 (en) The Treatment Of Ocular Conditions
PH32007000825S1 (en) Oval table
GB0700755D0 (en) The Treatment of ophthalmic diseases